Aurora Cannabis Inc (OTCMKTS: ACBFF) has been moving up steadily again in recent weeks on significant volume as October 17 nears. The stock has seen a spectacular rise over the past few years since trading below the $0.25 mark back in 2015.
Aurora Cannabis operates in the booming cannabis space responsible for many of the recent biggest winners in small caps. Everyone is counting down to October 17 when recreational marijuana will officially be legal for sale to adults aged at least 18 or 19, depending on the province, in licensed dispensaries. The Canadian recreational marijuana is forecasted to be worth at least $5 billion in annual sales
Aurora Cannabis Inc (TSE:ACB) (OTCMKTS: ACBFF) has angled itself to become the biggest producer in Canada with 140,000 kilograms by the end of 2018 and an astonishing 570,000 kilograms next year. Aurora Cannabis was founded by Terry Booth, Steve Dobler, Dale Lesak and Chris Mayerson in 2013. Using much of their own money the group initially secured a 160+ acre parcel of land in Mountain View County, Alberta. The company received its license to grow cannabis as well as its license to sell medical cannabis both in 2014.
Aurora bills itself as one of the world’s largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution. Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents.
The Company currently has 2 large organic projects including the Aurora Sun facility in Medicine Hat, Alberta, that’ll span 1.2mln square feet. Aurora Sky and Aurora Sun are expected to yield around 100,000 kilograms and 150,000 kilograms, respectively, a year as well as the 800,000-square-foot Aurora Sky facility
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora’s facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Pedanios, have achieved this level of certification.
Much of Auroras incredible growth has been fueled by acquisition; the Company has acquired 10 other Companies as well as invested in and established strategic partnerships with a range of leading innovators in the cannabis space.
To Find out the inside Scoop on Aurora Cannabis Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In August Aurora reached a license agreement with Alcanna whereby Alcanna has been given exclusive rights to open retail cannabis stores under the brand name Aurora across Canada. Alcanna’s position as the biggest private sector liquor retailer in Canada aligns with Aurora’s position as one of the world’s leading cannabis companies. Aurora has previously invested in Alcanna the Edmonton, Alberta-based retailer of alcoholic beverages with 229 retail outlets in Western Canada and Alaska.
The Company is also well positioned in Europe; Aurora subsidiary Pedanios in Germany reported European revenue of over 2.3 million Canadian dollars in its quarter ending March 31, 2018. Aurora’s production facility in Denmark should give it an advantage as more European markets open up. In addition, the company is looking to grow sales in other international markets, including Australia and Brazil.
Aurora has been making big announcements in recent days; last week the Company signed a definitive arrangement agreement to acquire South American Market Leader ICC Labs in an all-stock deal it valued at $290-million.
On September 12 Aurora announced it has acquired Europe’s largest producer, processor and supplier of certified organic hemp and hemp products, Agropro UAB as well as hemp processor and distributor Borela UAB.
Agropro, a hemp seed contracting and processing company, and its sister company Borela UAB a processor and distributor of organic hulled hemp seeds, hemp seed protein, hemp flour and hemp seed oil, currently has 1,600 hectares (4,000 acres) under contract, potentially yielding more than 1,000,000 kg of organic hemp with additional contracts available to expand to more than 3,000 hectares across Lithuania, Latvia, Estonia, and Poland.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a rapidly growing $6.6 billion market valuation Aurora has an excellent cash position with $231 million in the treasury and fast growing sales up over 100% year over year reporting $16.1 million in revenues for the 3 months ended March 31, 2018 up from $5.1 million for the same period in 2017. Aurora has worked its way to an estimated peak annual potential of 570,000 kilograms of cannabis through organic means, partnerships, and acquisitions making Aurora the top marijuana producer in the Country. We will be updating on Aurora Cannabis when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Aurora Cannabis.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Aurora Cannabis either long or short and we have not been compensated for this article.